Literature DB >> 26535603

Clinically Amyopathic Dermatomyositis Complicated by Pleural Effusion Case Report, Literature Review, and Proposed Mechanism.

Ying Wu, Sheetal Chhaya, Bert Hurowitz, Thomas Ardiles, Richard Carlson.   

Abstract

Polymyositis-dermatomyositis (PM-DM) is a chronic inflammatory disorder that mainly involves muscles and skin. Clinically amyopathic dermatomyositis (CADM) is a unique subset of PM-DM with typical skin manifestations but little or no evidence of musculoskeletal involvement. Many cases of dermatomyositis and CADM are associated with internal malignancy, but pulmonary manifestations can also been seen; the most common of which is interstitial lung disease. Pleural effusion is a rare complication and may be difficult to differentiate from other causes, such as infections, heart failure, or malignancy. We report a patient with CADM complicated by rapidly progressive pleural effusions. Based on findings of this patient, as well as literature review, we suggest that the etiology of massive pleural effusion in this setting is most likely related to local immune pleuritis associated with underlying interstitial lung disease due to dermatomyositis. Optimal management should be individualized and may include immunosuppressive agents, as well as antimicrobials, and potentially other agents.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26535603

Source DB:  PubMed          Journal:  Bull Hosp Jt Dis (2013)        ISSN: 2328-4633


  2 in total

1.  A case of dermatomyositis complicated with pleural effusion and massive ascites.

Authors:  Naoki Matsuoka; Tomoyuki Asano; Shuzo Sato; Tomomi Sasajima; Yuya Fujita; Jumpei Temmoku; Makiko Yashiro Furuya; Haruki Matsumoto; Eiji Suzuki; Hiroko Kobayashi; Hiroshi Watanabe; Kiyoshi Migita
Journal:  Fukushima J Med Sci       Date:  2019-12-11

2.  Anti-PL-7 Antisynthetase Syndrome with Eosinophilic Pleural Effusion.

Authors:  Go Saito; Masato Kono; Akari Tsutsumi; Yu Koyanagi; Koichi Miyashita; Takeshi Kobayashi; Hironao Hozumi; Yoshihiro Miki; Yoshifumi Arai; Yoshiro Otsuki; Dai Hashimoto; Tomoyuki Fujisawa; Toru Nakamura; Takafumi Suda; Hidenori Nakamura
Journal:  Intern Med       Date:  2018-03-09       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.